179 related articles for article (PubMed ID: 25747987)
21. Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma.
Chu TS; Chen JS; Lopez JP; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):979-84. PubMed ID: 18794444
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.
Pakunlu RI; Cook TJ; Minko T
Pharm Res; 2003 Mar; 20(3):351-9. PubMed ID: 12669953
[TBL] [Abstract][Full Text] [Related]
23. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a stem cell population in lung cancer A549 cells.
Sung JM; Cho HJ; Yi H; Lee CH; Kim HS; Kim DK; Abd El-Aty AM; Kim JS; Landowski CP; Hediger MA; Shin HC
Biochem Biophys Res Commun; 2008 Jun; 371(1):163-7. PubMed ID: 18423378
[TBL] [Abstract][Full Text] [Related]
25. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).
Pesić M; Andjelković T; Banković J; Marković ID; Rakić L; Ruzdijić S
Invest New Drugs; 2009 Apr; 27(2):99-110. PubMed ID: 18493718
[TBL] [Abstract][Full Text] [Related]
26. Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein.
Zhang FY; Du GJ; Zhang L; Zhang CL; Lu WL; Liang W
Pharm Res; 2009 Apr; 26(4):914-25. PubMed ID: 19067124
[TBL] [Abstract][Full Text] [Related]
27. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.
Bracht K; Kiefer T; Dölken G; Bednarski PJ
J Cancer Res Clin Oncol; 2007 Dec; 133(12):957-67. PubMed ID: 17562080
[TBL] [Abstract][Full Text] [Related]
28. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
[TBL] [Abstract][Full Text] [Related]
29. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
Pesić M; Podolski A; Rakić L; Ruzdijić S
Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
[TBL] [Abstract][Full Text] [Related]
30. Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.
Martin V; Xu J; Pabbisetty SK; Alonso MM; Liu D; Lee OH; Gumin J; Bhat KP; Colman H; Lang FF; Fueyo J; Gomez-Manzano C
Oncogene; 2009 Jun; 28(24):2358-63. PubMed ID: 19421150
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
Cagliero E; Ferracini R; Morello E; Scotlandi K; Manara MC; Buracco P; Comandone A; Baroetto Parisi R; Baldini N
Oncol Rep; 2004 Nov; 12(5):1023-31. PubMed ID: 15492788
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells.
Hui RC; Francis RE; Guest SK; Costa JR; Gomes AR; Myatt SS; Brosens JJ; Lam EW
Mol Cancer Ther; 2008 Mar; 7(3):670-8. PubMed ID: 18347152
[TBL] [Abstract][Full Text] [Related]
33. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells.
Horibe S; Nagai J; Yumoto R; Tawa R; Takano M
J Pharm Sci; 2011 Jul; 100(7):3010-7. PubMed ID: 21274848
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
[TBL] [Abstract][Full Text] [Related]
35. Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance.
Liu B; Qu L; Tao H
Cell Biol Int; 2009 Dec; 34(1):21-5. PubMed ID: 20001974
[TBL] [Abstract][Full Text] [Related]
36. APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer.
Stefanski CD; Arnason A; Maloney S; Kotsen J; Powers E; Zhang JT; Prosperi JR
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108784
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes.
Mercier C; Declèves X; Masseguin C; Fragner P; Tardy M; Roux F; Gabrion J; Scherrmann JM
J Neurochem; 2003 Nov; 87(4):820-30. PubMed ID: 14622113
[TBL] [Abstract][Full Text] [Related]
38. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells.
Emdad L; Lebedeva IV; Su ZZ; Sarkar D; Dent P; Curiel DT; Fisher PB
Mol Cancer Ther; 2007 Nov; 6(11):2985-94. PubMed ID: 18025283
[TBL] [Abstract][Full Text] [Related]
39. [Drug resistance mechanism of doxorubicin-resistant human gastric cancer cells BGC-823/DOX].
Zheng G; Han F; Liu X
Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):325-8. PubMed ID: 10374463
[TBL] [Abstract][Full Text] [Related]
40. Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells.
Mirzaei SA; Reiisi S; Ghiasi Tabari P; Shekari A; Aliakbari F; Azadfallah E; Elahian F
Sci Rep; 2018 Feb; 8(1):3446. PubMed ID: 29472576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
